Dasapan 50 mg Tablet

Dasapan 50 mg Tablet contains dasatinib, a tyrosine kinase inhibitor used to treat certain blood cancers. It is used for conditions including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Dasapan 50 mg Tablet works by blocking abnormal tyrosine kinase signals involved in the growth and survival of leukemia cells. Each tablet contains 50 mg of dasatinib and is formulated as an oral tablet. It can be taken with or without food according to the prescribed treatment schedule. Treatment should be initiated and monitored by a physician experienced in managing leukemia.

Technical Specification

Specification Details
Active Ingredient Dasatinib 50 mg
Dosage Form Film-Coated Tablet
Therapeutic Class Tyrosine Kinase Inhibitor
Main Indication Chronic Myeloid Leukemia
Route of Administration Oral
Storage Below 30°C

Product Also Known As

Dasapan 50 mg Tablet, Dasapan Dasatinib 50 mg Tablet, Dasatinib 50 mg Tablet, Dasatinib Film-Coated Tablet, Dasatinib CML Tablet, Dasatinib Oncology Tablet